Browse by author
Lookup NU author(s): Dr Clare TolleyORCiD, Professor Sarah SlightORCiD, Professor Andy HusbandORCiD, Neil Watson, Emeritus Professor David Bates
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© Copyright 2018, American Society of Health-System Pharmacists, Inc. All rights reserved. Purpose. Current uses of medication-related clinical decision support (CDS) and recommendations for improving these systems are reviewed. Summary. Using a systematic approach, articles published from 2007 through 2014 were identified in MEDLINE and EMBASE using MeSH terms and keywords relating to the 5 basic medication-related CDS functionalities. A total of 156 full-text articles and 28 conference abstracts were reviewed across each of the 5 areas: drug-drug interaction (DDI) checks (n = 78), drug allergy checks (n = 20), drug dose support (n = 55), drug duplication checks (n = 11), and drug formulary support (n = 20). The success of medication-related CDS depends on users finding the alerts valuable and acting on the information received. Improving alert specificity and sensitivity is important for all domains. Tiering is important for improving the acceptance of DDI alerts. The ability to perform appropriate crosssensitivity checks is key to producing appropriate drug allergy checks. Drug dosage alerts should be individualized and deliver practical recommendations. How the system is configured to identify certain drug duplications is important to prevent possible patient toxicity. Accurate knowledge databases are needed to produce relevant drug formulary alerts and encourage formulary adherence. Medication-related CDS is still relatively immature in some organizations and has substantial room for improvement. For example, decision support should consider more patient-specific factors, human factors principles should always be considered, and alert specificity must be improved in order to reduce alert fatigue. Conclusion. Standardization, integration of patient-specific parameters, and consideration of human factors design principles are central to realizing the potential benefits of medication-related CDS.
Author(s): Tolley CL, Slight SP, Husband AK, Watson N, Bates DW
Publication type: Review
Publication status: Published
Journal: American Journal of Health-System Pharmacy
Year: 2018
Volume: 75
Issue: 4
Pages: 239-246
Print publication date: 15/02/2018
Online publication date: 07/02/2018
Acceptance date: 02/04/2016
ISSN (print): 1079-2082
ISSN (electronic): 1535-2900
Publisher: American Society of Health-Systems Pharmacy
URL: https://doi.org/10.2146/ajhp160830
DOI: 10.2146/ajhp160830
